CORT EPS Estimates
Corcept Therapeutics Incorporated
$116.45
+$4.35(+3.88%)
40
Overall
25
Value
41
Tech
55
Quality
Market Cap
$12.59B
Volume
549.25K
52W Range
$28.66 - $126.38
Target Price
$139.67
CORT EPS estimates: the consensus estimate for Corcept Therapeutics Incorporated's current fiscal year is $1.83 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CORT EPS Estimates
- EPS estimate, current quarter
- $0.68
- EPS estimate, next quarter
- $0.98
- EPS estimate, current year
- $1.83
- EPS estimate, next year
- $3.49
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.95 |
| 2024 | $1.35 |
| 2023 | $1.02 |
| 2022 | $0.95 |
| 2021 | $0.97 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $116.45 | +3.9% | 549.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW